Document
type: Class

Academic Article
type: Class

Continuant
type: Class

Inglese
type: Language

Entity
type: Class

Generically Dependent Continuant
type: Class

individual
rights: termsOfUse
date: 2026-08-26T11:28:15
publisher: http://irises.unibs.it/resource/item/19449
type: Document
label: RDF description of Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients - http://irises.unibs.it/resource/item/19449

3109821
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: http://irises.unibs.it/resource/item/19449

Article
type: Class

3109822
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: http://irises.unibs.it/resource/item/19449

Information Content Entity
type: Class

http://irises.unibs.it/resource/item/19449
language: Inglese
type: Document
type: Information Content Entity
type: Generically Dependent Continuant
type: Continuant
type: Entity
related by: 3109821
label: Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients
related by: 3109822
type: Article
type: Thing
most specific type: Academic Article
type: Academic Article